z-logo
open-access-imgOpen Access
Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications
Author(s) -
Zhang S.,
Shu X.,
Tian X.,
Chen F.,
Lu X.,
Wang G.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12319
Subject(s) - polymyositis , dermatomyositis , interstitial lung disease , medicine , neutrophil extracellular traps , extracellular , pathology , disease , lung , inflammation , immunology , biology , microbiology and biotechnology
Summary Dermatomyositis ( DM ) and polymyosits ( PM ) are systemic autoimmune diseases whose pathogeneses remain unclear. Neutrophil extracellular traps ( NET s) are reputed to play an important role in the pathogenesis of autoimmune diseases. This study tests the hypothesis that NET s may be pathogenic in DM / PM . Plasma samples from 97 DM / PM patients (72 DM , 25 PM ) and 54 healthy controls were tested for the capacities to induce and degrade NET s. Plasma DN ase I activity was tested to further explore possible reasons for the incomplete degradation of NET s. Results from 35 DM patients and seven PM patients with interstitial lung disease ( ILD ) were compared with results from DM / PM patients without ILD . Compared with control subjects, DM / PM patients exhibited a significantly enhanced capacity for inducing NETs , which was supported by elevated levels of plasma LL ‐37 and circulating cell‐free DNA (cf DNA ) in DM / PM . NET s degradation and DN ase I activity were also decreased significantly in DM / PM patients and were correlated positively. Moreover, DM / PM patients with ILD exhibited the lowest NET s degradation in vitro due to the decrease in DN ase I activity. DN ase I activity in patients with anti‐ J o‐1 antibodies was significantly lower than in patients without. Glucocorticoid therapy seems to improve DN ase I activity. Our findings demonstrate that excessively formed NET s cannot be degraded completely because of decreased DN ase I activity in DM / PM patients, especially in patients with ILD , suggesting that abnormal regulation of NETs may be involved in the pathogenesis of DM / PM and could be one of the factors that initiate and aggravate ILD .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom